PUNE, India, April 19, 2017 /PRNewswire/ --
Celiac Disease - Pipeline Review, H1 2017 is a latest Pharmaceuticaland Healthcare disease pipeline guide that provides an overview of the Celiac Disease (Gastrointestinal) pipeline landscape. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery
Browse 169 Tables 83 Figures, 11 Major Company Profiles, spread across 119 pages available at http://www.reportsnreports.com/reports/958314-celiac-disease-pipeline-review-h1-2017.html.
Celiac Disease - Companies Involved in Therapeutics Development are Amgen Inc, Amyra Biotech AG, Calypso Biotech SA, Circle33 LLC, enGene Inc, F. Hoffmann-La Roche Ltd, Glenmark Pharmaceuticals Ltd, ImmusanT Inc, Innovate Biopharmaceuticals Inc, Intrexon Corp, Sanofi, Takeda Pharmaceutical Company Ltd and Zedira GmbH
Celiac Disease - Drug Profiles: AMG-714, AVX-176
Biologic for Celiac Disease - Drug Profile: BNZ-2, CALY-002, ERW-1041E, GBR-830, Kuma-010, larazotide acetate and latiglutenase
Monoclonal Antibody to Antagonize IL-2R Beta for Celiac Disease, Tropical Spastic Paraparesis and Oncology - Drug Profiles: Nexvax-2, Nexvax-3
This pipeline guide provides a snapshot of the global therapeutic landscape of Celiac Disease (Gastrointestinal). It reviews pipeline therapeutics for Celiac Disease (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources. The Celiac Disease (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Celiac Disease and features dormant and discontinued projects.
Order a Copy of Report at http://www.reportsnreports.com/purchase.aspx?name=958314.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. The pipeline guide reviews key companies involved in Celiac Disease (Gastrointestinal) therapeutics and enlists all their major and minor projects. The pipeline guide evaluates Celiac Disease (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide reviews latest news related to pipeline therapeutics for Celiac Disease (Gastrointestinal).
Reasons to buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Celiac Disease (Gastrointestinal). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Celiac Disease (Gastrointestinal) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Other New Reports:
Pancreatitis - Pipeline Review, H1 2017
Friedreich Ataxia - Pipeline Review, H1 2017
Pyelonephritis - Pipeline Review, H1 2017
Explore more reports on Pharmaceuticals Market at http://www.reportsnreports.com/market-research/pharmaceuticals/.
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Contact: Ritesh Tiwari 2nd Floor, Metropole Building, Next to Inox Theatre, Bund Garden Road, Pune - 411013. Maharashtra, India. + 1-888-391-5441 email@example.com
Connect with Us: LinkedIn: http://www.linkedin.com/company/reportsnreports RSS/Feeds: http: //http://www.reportsnreports.com/feed/l-latestreports.xml
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All